Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 2/3 2Phase NA 1Phase 4 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Intracranial Germ Cell CNS Tumor, Childhood 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × EC regimen × Clear all
NCT06698965 2024-11-21

Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin

Shanghai Chest Hospital

Phase 2 Recruiting
52 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05834582 2023-04-28

Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Unknown
60 enrolled
Breast

Triple Negative Breast Neoplasms

NCT05124951 2021-11-18

The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors

Beijing Tiantan Hospital

Phase 2 Recruiting
150 enrolled

Intracranial Germ Cell CNS Tumor, Childhood

Data powered by HemOnc (CC BY 4.0) Colophon âš¡